🇺🇸 FDA
Pipeline program

OGX-011

R04-0092

Phase 2 mab completed

Quick answer

OGX-011 for Prostate Cancer is a Phase 2 program (mab) at UNITED THERAPEUTICS Corp with 1 ClinicalTrials.gov record(s).

Program details

Company
UNITED THERAPEUTICS Corp
Indication
Prostate Cancer
Phase
Phase 2
Modality
mab
Status
completed

Clinical trials